COMMUNIQUÉ DE PRESSE publié le 15/05/2024 à 22:05, il y a 1 année 11 mois SWK Holdings Corporation Announces Financial Results for First Quarter 2024 SWK Holdings Corporation announces first quarter 2024 financial and operating results, with $11.8 million total revenue and $0.9 million GAAP net income. Join the conference call on May 16, 2024, at 10:00 a.m. ET for more details Financial Results Conference Call SWK Holdings Corporation First Quarter 2024 Finance Segment
BRÈVE publiée le 21/03/2024 à 12:05, il y a 2 années 1 mois SWK Holdings Corporation annonce des résultats financiers positifs pour le quatrième trimestre 2023 Résultats Financiers T4 2023 Financement Spécialisé SWK Holdings Financement Des Sciences De La Vie
BRÈVE publiée le 21/03/2024 à 12:05, il y a 2 années 1 mois SWK Holdings Corporation Reports Positive Financial Results for Q4 2023 Financial Results Life Science Finance Q4 2023 Specialty Finance SWK Holdings
COMMUNIQUÉ DE PRESSE publié le 21/03/2024 à 12:00, il y a 2 années 1 mois SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2023 SWK Holdings Corporation announces business update and financial results for Q4 2023, showcasing $2.8 million net income. Includes details on senior notes offering, share repurchases, and Exclusive Option and Asset Purchase Agreement Financial Results Net Income SWK Holdings Corporation Senior Notes Offering Exclusive Option And Asset Purchase Agreement
COMMUNIQUÉ DE PRESSE publié le 23/01/2024 à 22:05, il y a 2 années 3 mois SWK Holdings Highlights Recent Achievements and Provides Portfolio Update SWK Holdings Corporation provided a corporate progress update and summarized the achievements of its borrower partners, closing approximately $60 million of financings with $55 million deployed in the fourth quarter of 2023. The portfolio of life science finance receivables grew to an all-time high as of December 31, 2023, positioning the company for sustained growth and positive returns to shareholders through selective investment in innovative life science companies. SWK Holdings Corporation Life Science Finance Small And Mid-sized Companies Corporate Progress Portfolio Updates
Publié le 07/05/2026 à 19:15, il y a 2 jours 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Publié le 07/05/2026 à 19:15, il y a 2 jours Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Publié le 07/05/2026 à 19:06, il y a 2 jours Disclosure of Share Capital and Voting Rights as of April 30, 2026
Publié le 07/05/2026 à 19:06, il y a 2 jours Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Publié le 07/05/2026 à 19:00, il y a 2 jours ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 09/05/2026 à 01:30, il y a 17 heures 49 minutes Star Copper Announces Agreement with Zimtu Capital Corp.
Publié le 09/05/2026 à 00:00, il y a 19 heures 19 minutes Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Publié le 09/05/2026 à 19:05, il y a 14 minutes LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Publié le 08/05/2026 à 20:38, il y a 22 heures 41 minutes EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Publié le 08/05/2026 à 19:12, il y a 1 jour EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Publié le 08/05/2026 à 19:02, il y a 1 jour Metall Zug – Annual General Meeting of Shareholders approves all proposals